NICE medical technologies guidance January 2019
- The case for adopting Senza spinal cord stimulation (SCS) for delivering HF10 therapy as a treatment option for chronic neuropathic back or leg pain after failed back surgery is supported by the evidence.
- NICE has developed tools, in association with relevant stakeholders, to help organisations put this guidance into practice.
